Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Valuation vs Instaport thresholds (P/E, PEG, P/FCF, P/S)
Licensed market data — shown to members, not published to the open web.
Profile
From SEC filingsCompany description
We are in the process of repositioning our operations toward BCI technologies and related artificial intelligence-enabled healthcare, general wellness, rehabilitation, and biotechnology solutions. Disposition of Prior Professional Education and STEM Education Businesses Following the completion of Divestiture 2024 and Disposition 2025, we have fully divested our prior professional education and STEM education businesses and ceased all operations related thereto. As a result, the Company has undergone a strategic business transformation and is now focused exclusively on the development of brain-computer interface, or BCI, technologies and related businesses as described herein. Brain-Computer Interface (BCI) Business Our BCI business is expected to be centered on the development and application of core algorithms, as well as related software and hardware systems for brain-computer interaction. Through these capabilities, we intend to develop, procure, sell, and distribute BCI-enabled or BCI-adjacent products and solutions, and to provide related technical services. Our Mission Our mission is to use intelligent systems to connect technological innovation with practical applications and to provide individuals, institutions, and commercial organizations with technology-enabled solutions in healthcare, rehabilitation, general wellness management, and related fields. We believe that BCI technology may become an important interface between biological signals, artificial intelligence, software systems, hardware devices, and external control applications.
Read the full filing description · filed 11 May 2026
At a glance
- Sector
- Industrials
- Industry
Source: SEC filings. Information and analytics, not investment advice.